 VANCOUVER, Canada and HOUSTON, Texas, Aug. 31, 2021 PRNewswire - ESSA Pharma Inc. ESSA, or the Company NASDAQ: EPIX, a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that David R. Parkinson, President and Chief Executive Officer of ESSA Pharma, will be presenting and hosting one-on-one meetings with investors at two upcoming virtual investor conferences. 